Difference between revisions of "Part:BBa K4905020"

 
 
Line 3: Line 3:
 
<partinfo>BBa_K4905020 short</partinfo>
 
<partinfo>BBa_K4905020 short</partinfo>
  
−
IL-10 for the treatment of Inflammatory bowel disease
+
<html>
−
 
+
<body>
−
<!-- Add more about the biology of this part here
+
<p>
−
===Usage and Biology===
+
This composite part is made with the basic parts Pectate Lyase B (PelB) (<a href="https://parts.igem.org/Part:BBa_K2302005">BBa_K2302005</a>), Interleukin 10 (IL-10) (<a href="https://parts.igem.org/Part:BBa_K554004">BBa_K554004</a>), and Polyhistadine-tag (His-tag) (<a href="https://parts.igem.org/Part:BBa_K3630006">BBa_K3630006</a>). This forms the construct PelB-IL10-His. The TU Eindhoven 2023 team used it as a therapeutic against Inflammatory Bowel disease (IBD).
 +
</p>
 +
<p>
 +
IL-10 is important for regulating inflammation<sup>[1]</sup>. It is immunosuppressive with effect on macrophages and dendritic cells. Animal studies show that mice with IL-10 deficiency develop severe colitis, but not when recombinant IL-10 is systemically applied. With the anti-inflammatory effect of IL-10, it can be used to treat IBD and other autoimmune disorders. However, an oral intake or injection with only IL-10 induces side effects. The options are also limited because of the acid sensitivity of IL-10. Genetically modified organisms are an alternative for delivering IL-10 at the right place of the inflammation. In our case with <i>E.coli</i> BL21 cells as carrier.
 +
</p>
 +
<p>
 +
For the expression of IL-10 by <i>E.coli</i>, a signal sequence is needed for the efficient production with the Sec secretion pathway. This is why PelB is added to IL-10. On the other side of IL-10, we added a His-tag. This is used for affinity purification of the construct.
 +
</p>
  
 +
</body>
 +
</html>
 
<!-- -->
 
<!-- -->
−
<span class='h3bb'>Sequence and Features</span>
+
<span class='h3bb'><h1>Sequence and Features</h1></span>
 
<partinfo>BBa_K4905020 SequenceAndFeatures</partinfo>
 
<partinfo>BBa_K4905020 SequenceAndFeatures</partinfo>
  
−
 
+
<html>
−
<!-- Uncomment this to enable Functional Parameter display
+
<body>
−
===Functional Parameters===
+
<h1>References</h1>
−
<partinfo>BBa_K4905020 parameters</partinfo>
+
<p>
−
<!-- -->
+
[1] Pöhlmann, C., Brandt, M., Mottok, D. S., Zschüttig, A., Campbell, J. W., Blattner, F. R., Frisch, D., & Gunzer, F. (2012). Periplasmic Delivery of Biologically Active Human Interleukin-10 in Escherichia coli via a Sec-Dependent Signal Peptide. Journal of Molecular Microbiology and Biotechnology, 22(1), 1–9. https://doi.org/10.1159/000336043
 +
</p>
 +
</body>
 +
</html>

Latest revision as of 08:15, 3 October 2023


PelB-IL10-His

This composite part is made with the basic parts Pectate Lyase B (PelB) (BBa_K2302005), Interleukin 10 (IL-10) (BBa_K554004), and Polyhistadine-tag (His-tag) (BBa_K3630006). This forms the construct PelB-IL10-His. The TU Eindhoven 2023 team used it as a therapeutic against Inflammatory Bowel disease (IBD).

IL-10 is important for regulating inflammation[1]. It is immunosuppressive with effect on macrophages and dendritic cells. Animal studies show that mice with IL-10 deficiency develop severe colitis, but not when recombinant IL-10 is systemically applied. With the anti-inflammatory effect of IL-10, it can be used to treat IBD and other autoimmune disorders. However, an oral intake or injection with only IL-10 induces side effects. The options are also limited because of the acid sensitivity of IL-10. Genetically modified organisms are an alternative for delivering IL-10 at the right place of the inflammation. In our case with E.coli BL21 cells as carrier.

For the expression of IL-10 by E.coli, a signal sequence is needed for the efficient production with the Sec secretion pathway. This is why PelB is added to IL-10. On the other side of IL-10, we added a His-tag. This is used for affinity purification of the construct.

Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    INCOMPATIBLE WITH RFC[25]
    Illegal NgoMIV site found at 25
    Illegal NgoMIV site found at 51
  • 1000
    COMPATIBLE WITH RFC[1000]

References

[1] Pöhlmann, C., Brandt, M., Mottok, D. S., Zschüttig, A., Campbell, J. W., Blattner, F. R., Frisch, D., & Gunzer, F. (2012). Periplasmic Delivery of Biologically Active Human Interleukin-10 in Escherichia coli via a Sec-Dependent Signal Peptide. Journal of Molecular Microbiology and Biotechnology, 22(1), 1–9. https://doi.org/10.1159/000336043